Literature DB >> 17921994

AAV vectors and tumorigenicity.

Mark A Kay1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17921994     DOI： 10.1038/nbt1007-1111

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  19 in total

Review 1.  Emerging therapeutic approaches in the management of retinal angiogenesis and edema.

Authors:  An Truong; Tien Y Wong; Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2010-12-18       Impact factor: 4.599

Review 2.  Polymeric nucleic acid carriers: current issues and novel design approaches.

Authors:  Han Chang Kang; Kang Moo Huh; You Han Bae
Journal:  J Control Release       Date:  2012-07-04       Impact factor: 9.776

Review 3.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

Review 4.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 5.  State-of-the-art gene-based therapies: the road ahead.

Authors:  Mark A Kay
Journal:  Nat Rev Genet       Date:  2011-04-06       Impact factor: 53.242

6.  rAAV-mediated tumorigenesis: still unresolved after an AAV assault.

Authors:  Paul N Valdmanis; Leszek Lisowski; Mark A Kay
Journal:  Mol Ther       Date:  2012-11       Impact factor: 11.454

7.  Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction.

Authors:  Mikako Ito; Yumi Suzuki; Takashi Okada; Takayasu Fukudome; Toshiro Yoshimura; Akio Masuda; Shin'ichi Takeda; Eric Krejci; Kinji Ohno
Journal:  Mol Ther       Date:  2012-02-28       Impact factor: 11.454

Review 8.  Update on clinical gene therapy for hemophilia.

Authors:  George Q Perrin; Roland W Herzog; David M Markusic
Journal:  Blood       Date:  2018-12-17       Impact factor: 22.113

9.  Reconstitutable charged polymeric (PLGA)(2)-b-PEI micelles for gene therapeutics delivery.

Authors:  Deepa Mishra; Han Chang Kang; You Han Bae
Journal:  Biomaterials       Date:  2011-02-26       Impact factor: 12.479

Review 10.  Barriers for retinal gene therapy: separating fact from fiction.

Authors:  Rajendra Kumar-Singh
Journal:  Vision Res       Date:  2008-06-18       Impact factor: 1.886
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.